Résultats de la recherche

(1 - 20 of 22)

Pages

Exporter

Murine models for pharmacological studies of the metabolic syndrome

Murine models for pharmacological studies of the metabolic syndrome: Pas de texte intégral; Fellmann Lyne, Nascimento A, Tibirica E, Bousquet Pascal; Articles Scientifiques; 2012-11-23; Pharmacology and Therapeutics; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

03-P008 : Improvement of insulin sensitivity by imidazoline-like drugs in rats

03-P008 : Improvement of insulin sensitivity by imidazoline-like drugs in rats: Pas de texte intégral; Niederhoffer Nathalie, Bouchoucha S, Greney Hugues, Bousquet Pascal; Conférences; 2012-04-08; 2012-04-08; Fundamental and Clinical Pharmacology; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

CO-015 : Imidazoline I1 receptor ligands activate hepatic adiponectin pathways and thus improve insulin sensitivity

CO-015 : Imidazoline I1 receptor ligands activate hepatic adiponectin pathways and thus improve insulin sensitivity: Pas de texte intégral; Weiss Maud, Benameur Djamil, Bousquet Pascal, Niederhoffer Nathalie, Greney Hugues; Conférences; 2014-04-25; 2014-04-25; Fundamental and Clinical Pharmacology; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

0260 : Imidazoline I1 receptor ligands activate hepatic adiponectin pathways and thus improve insulin sensitivity

0260 : Imidazoline I1 receptor ligands activate hepatic adiponectin pathways and thus improve insulin sensitivity: Accès libre Peer reviewed; Weiss Maud, Benameur Djamil, Bousquet Pascal, Niederhoffer Nathalie, Greney Hugues; Conférences; 2014-04; 2014-04; Archives of cardiovascular diseases supplements; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

0321 : Imidazoline-like drug improve insulin sensitivity through a direct stimulation of adiponectin secretion in primary adipocytes

0321 : Imidazoline-like drug improve insulin sensitivity through a direct stimulation of adiponectin secretion in primary adipocytes: Pas de texte intégral; Weiss Maud, Traversi Florian, Bousquet Pascal, Greney Hugues, Niederhoffer Nathalie; Conférences; 2015-05-06; 2015-05-06; Archives of Cardiovascular Diseases Supplements; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

CO-007 : Imidazoline-like drug improve insulin sensitivity through a direct stimulation of adiponectin secretion in primary adipocytes

CO-007 : Imidazoline-like drug improve insulin sensitivity through a direct stimulation of adiponectin secretion in primary adipocytes: Pas de texte intégral; Weiss Maud, Traversi Florian, Bousquet Pascal, Greney Hugues, Niederhoffer Nathalie; Conférences; 2015-03-17; 2015-03-17; Fundamental and Clinical Pharmacology; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

11-02 : Effects of imidazoline-like drugs on insulin sensitivity and adiponectin pathway

11-02 : Effects of imidazoline-like drugs on insulin sensitivity and adiponectin pathway: Pas de texte intégral; Niederhoffer Nathalie, Bouchoucha S, Weiss Maud, Greney Hugues, Bousquet Pascal; Conférences; 2013-04-25; 2013-04-25; Fundamental and Clinical Pharmacology; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

CASD 002 : Cardiac muscarinic receptor overexpression in sudden infant death syndrome

CASD 002 : Cardiac muscarinic receptor overexpression in sudden infant death syndrome: Pas de texte intégral; Bousquet Pascal, Livolsi Angelo, Niederhoffer Nathalie, Olexa Catherine, Mokni Walid; Conférences; 2011-10-20; 2011-10-20; Fundamental and Clinical Pharmacology; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

Sympathetic overactivity as an early manifestation of metabolic syndrome

Sympathetic overactivity as an early manifestation of metabolic syndrome**: Pas de texte intégral; Habib S, van de Born P, Mokni W, Sauleau E, Frick V, Simon A, Niederhoffer Nathalie, Zannad F, Brandt C, Bousquet Pascal; Conférences; 2013; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

Cardiac muscarinic receptor overexpression in sudden infant death syndrome

Cardiac muscarinic receptor overexpression in sudden infant death syndrome: Pas de texte intégral; Livolsi Angelo, Niederhoffer Nathalie, Dali-Youcef N, Rambaud C, Olexa C, Mokni W, Gies J, Bousquet Pascal; Conférences; 2011; 2011; European Heart Journal; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

Cardiac muscarinic receptor overexpression as a possible cause of vagal hyperreactivity

Cardiac muscarinic receptor overexpression as a possible cause of vagal hyperreactivity: Pas de texte intégral; Livolsi Angelo, Niederhoffer Nathalie, Dali-Youcef N, Mokni W, Olexa C, Gies J, Feldman J, Bousquet Pascal; Conférences; 2011; 2011; European Heart Journal; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

0145 : Involvement of the sympathetic nervous system in the development of metabolic disorders

0145 : Involvement of the sympathetic nervous system in the development of metabolic disorders: Accès libre Peer reviewed; Aubertin-Kirch Gaëlle, Weiss Maud, Traversi Florian, Bousquet Pascal, Monassier Laurent, Niederhoffer Nathalie; Conférences; 2015-05-06; 2015-05-06; Archives of Cardiovascular Diseases Supplements; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome

Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome: Pas de texte intégral; Gasparik Vincent, Greney Hugues, Schann Stephan, Feldman Josiane, Fellmann Lyne, Ehrhardt Jean-Daniel, Bousquet Pascal; Articles Scientifiques; 2014-12-18; Journal of Medicinal Chemistry; Laboratoire d'Innovation Thérapeutique - LIT - UMR7200
Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

129 : Cardiac muscarinic receptor overexpression as a possible cause of vagal hyperreactivity

129 : Cardiac muscarinic receptor overexpression as a possible cause of vagal hyperreactivity: Pas de texte intégral; Livolsi Angelo, Niederhoffer Nathalie, Dali-Youcef N, Mokni W, Olexa C, Gies J, Feldman J, Bousquet Pascal; Conférences; 2010-03-08; 2010-03-08; Fundamental and Clinical Pharmacology; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

Evidence for an improvement of glucose tolerance by activation of peripheral imidazoline receptors in rats

Evidence for an improvement of glucose tolerance by activation of peripheral imidazoline receptors in rats: Pas de texte intégral; Niederhoffer Nathalie, Aiad F, Gigou L., Doras C, De Tapia C, Greney Hugues, Bousquet Pascal; Conférences; 2011-03-28; 2011-03-28; Fundamental and Clinical Pharmacology; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in rats

A new pyrroline compound selective for I1-imidazoline receptors improves metabolic syndrome in rats: Pas de texte intégral; Fellmann L, Regnault V, Greney Hugues, Gaspari V, Muscat A, Max J, Gigou L, Orea V, Chetrite G, Pizard A, Niederhoffer Nathalie, Julien C, Lacolley P, Feve B, Bousquet Pascal; Articles Scientifiques; 2013-07-01; Journal of Pharmacology and Experimental Therapeutics; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

308 : Cardiac muscarinic receptor overexpression in sudden infant death syndrome

308 : Cardiac muscarinic receptor overexpression in sudden infant death syndrome: Pas de texte intégral; Livolsi Angelo, Niederhoffer Nathalie, Dali-Youcef N, Rambaud C, Olexa Catherine, Mokni W, Gies Jean-Pierre, Bousquet Pascal; Conférences; 2011-03-28; 2011-03-28; Fundamental and Clinical Pharmacology; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296
Laboratoire de Biophotonique et Pharmacologie - LBP - UMR7213

Methylation of imidazoline related compounds leads to loss of alpha(2)-adrenoceptor affinity. Synthesis and biological evaluation of selective I(1) imidazoline receptor ligands

Methylation of imidazoline related compounds leads to loss of alpha(2)-adrenoceptor affinity. Synthesis and biological evaluation of selective I(1) imidazoline receptor ligands: Pas de texte intégral; Schann Stephan, Greney Hugues, Gasparik Vincent, Dontenwill Monique, Rascente Carla, Lacroix Gabriel, Monassier Laurent, Bruban-Schann Veronique, Feldman Josiane, Ehrhardt Jean-Daniel, Bousquet Pascal; Articles Scientifiques; 2012-06-09; Bioorganic & medicinal chemistry; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296
Laboratoire d'Innovation Thérapeutique - LIT - UMR7200
Laboratoire de Biophotonique et Pharmacologie - LBP - UMR7213

Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intolerance

Imidazoline-like drugs improve insulin sensitivity through peripheral stimulation of adiponectin and AMPK pathways in a rat model of glucose intolerance: Pas de texte intégral; Weiss Maud, Bouchoucha Soumaya, Aiad Farouk, Ayme-Dietrich Estelle, Dali-Youcef Nassim, Bousquet Pascal, Greney Hugues, Niederhoffer Nathalie; Articles Scientifiques; 2015-05-26; AJP - Endocrinology and Metabolism; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296
Institut de Génétique et de Biologie Moléculaire et Cellulaire - IGBMC - UMRS964

An I1-imidazoline receptor agonist causes sympatho-inhibition and adiponectin secretion stimulation in rats: a new way to treat metabolic syndrome?

An I1-imidazoline receptor agonist causes sympatho-inhibition and adiponectin secretion stimulation in rats: a new way to treat metabolic syndrome?**: Pas de texte intégral; Fellmann L, Regnault V, Greney Hugues, Gasparik V, Muscat A, Max J, Gigou L, Oréa V, Chetrite G, Niederhoffer Nathalie, Julien C, Lacolley P, Fève B, Bousquet Pascal; Conférences; 2013; Laboratoire de neurobiologie et pharmacologie cardiovasculaire - LNPCV – EA7296

Pages

Islandora displays